These results are in line with earlier findings where GNAI1 was shown to suppress hepatocellular carcinoma metastasis via inhibition of the RhoA-ROCK pathway [45], and GNAI2/3 suppressed glioma growth through PI3K/AKT inhibition [46]. Here, AKT1 is linked to central nervous system cancer.